Sorted By:

Relevance


Meet the Chart Pack

PhRMA  |  Blog Post

For now, flip through the Chart Pack and see what else you can find.
http://catalyst.phrma.org/meet-the-chart-pack

Biosimilars Naming

PhRMA  |  Fact Sheet

Naming for biologics and biosimilars remains an outstanding issue on which the U.S. Food and Drug Administration (FDA) must finalize regulations. The FDA has issued a draft guidance on nonproprietary naming for biologic medicines, proposing that all original biologic medicines and biosimilars sha...
https://www.phrma.org/fact-sheet/biosimilars-naming

RxE HCV in Illinois

PhRMA  |  Fact Sheet

The past couple years have seen a transformation in treatment with the introduction of a new generation of HCV medicines which provide cure rates upwards of 90% with minimal side effects and in as little as 8 weeks.
https://www.phrma.org/fact-sheet/rxe-hcv-in-illinois

Key Facts Card

PhRMA  |  Fact Sheet

Industry facts from research and development to value of medicines to economic impact are outlined in the Fact Sheet below.
https://www.phrma.org/fact-sheet/key-facts-card

Connecticut's 2016 Exchange Plans

PhRMA  |  Fact Sheet

Potential Size of Exchange Market: About 292,000 Connecticut residents State oversight can help ensure that health insurance exchange coverage offers the access to needed medicines the Affordable Care Act promised. States can continue to protect patients in their state ...
https://www.phrma.org/fact-sheet/connecticut-s-2016-exchange-plans

Vermont's 2016 Exchange Plans

PhRMA  |  Fact Sheet

Potential Size of Exchange Market: About 60,000 Vermont residents State oversight can help ensure that health insurance exchange coverage offers the access to needed medicines the Affordable Care Act promised. States can continue to protect patients in their state throu...
https://www.phrma.org/fact-sheet/vermont-s-2016-exchange-plans

Patient-Focused Drug Development

PhRMA  |  Fact Sheet

Patient-focused drug development (PFDD) incorporates the patient’s voice in the development and the U.S. Food and Drug Administration’s (FDA) evaluation of new medicines. During clinical trials, researchers study whether new medicines are safe and effective for patients and whether the medicine’s...
https://www.phrma.org/fact-sheet/patient-focused-drug-development

New report highlights need to speed patent examination

PhRMA  |  Blog Post

Lost in this is the fact that many countries have patent review and processing systems that have become inefficient and unable to keep pace with the accelerating speed of innovation across all industry sectors, including in the life sciences and biopharmaceutical industry.
http://catalyst.phrma.org/new-report-highlights-need-to-speed-patent-examination

RxE HCV in Louisiana

PhRMA  |  Fact Sheet

The past couple years have seen a transformation in treatment with the introduction of a new generation of HCV medicines which provide cure rates upwards of 90% with minimal side effects and in as little as 8 weeks.
https://www.phrma.org/fact-sheet/rxe-hcv-in-louisiana

Wisconsin's 2016 Exchange Plans

PhRMA  |  Fact Sheet

Potential Size of Exchange Market: About 513,000 Wisconsin residents State oversight can help ensure that health insurance exchange coverage offers the access to needed medicines the Affordable Care Act promised. States can continue to protect patients in their state th...
https://www.phrma.org/fact-sheet/wisconsin-s-2016-exchange-plans

Illinois' 2016 Exchange Plans

PhRMA  |  Fact Sheet

Potential Size of Exchange Market: About 836,000 Illinois residents State oversight can help ensure that health insurance exchange coverage offers the access to needed medicines the Affordable Care Act promised. States can continue to protect patients in their state thr...
https://www.phrma.org/fact-sheet/illinois-2016-exchange-plans

Kentucky's 2016 Exchange Plans

PhRMA  |  Fact Sheet

Potential Size of Exchange Market: About 248,000 Kentucky residents State oversight can help ensure that health insurance exchange coverage offers the access to needed medicines the Affordable Care Act promised. States can continue to protect patients in their state thr...
https://www.phrma.org/fact-sheet/kentucky-s-2016-exchange-plans

What is PDUFA VI?

PhRMA  |  Fact Sheet

For nearly 25 years, the Prescription Drug User Fee Act (PDUFA) has provided greater consistency, certainty and predictability for the U.S. Food and Drug Administration’s (FDA) human drug review program and has helped to bring safe and effective innovative medicines to patients. Because of PDUFA,...
https://www.phrma.org/fact-sheet/what-is-pdufa-vi

Delaware's 2016 Exchange Plans

PhRMA  |  Fact Sheet

Potential Size of Exchange Market: About 60,000 Delaware residents State oversight can help ensure that health insurance exchange coverage offers the access to needed medicines the Affordable Care Act promised. States can continue to protect patients in their state thro...
https://www.phrma.org/fact-sheet/delaware-s-2016-exchange-plans

Massachusetts' 2016 Exchange Plans

PhRMA  |  Fact Sheet

Potential Size of Exchange Market: About 353,000 Massachusetts residents State oversight can help ensure that health insurance exchange coverage offers the access to needed medicines the Affordable Care Act promised. States can continue to protect patients in their stat...
https://www.phrma.org/fact-sheet/massachusetts-2016-exchange-plans

Patient Cost Sharing Rising

PhRMA  |  Fact Sheet

New data show changes in how insurers structure health insurance benefits have made out-of-pocket costs harder for patients to budget for or predict. A Kaiser Family Foundation analysis finds patients are paying more out-of-pocket through deductibles and coinsurance, while copayments are going do...
https://www.phrma.org/fact-sheet/patient-cost-sharing-rising

Fact Check Friday: Biopharmaceutical company communications with payers

PhRMA  |  Blog Post

We further applaud Congress’ focus on this issue as seen in the 21st Century Cures Act and look forward to continued work on this important matter.
http://catalyst.phrma.org/fact-check-friday-biopharmaceutical-company-communications-with-payers

Key Facts Card

PhRMA  |  Fact Sheet

Relentless scientific inquiry in drug development is shifting the odds in the fight against some of the world’s most challenging diseases....
https://www.phrma.org/fact-sheet/key-facts-card1

Biosimilars Labeling

PhRMA  |  Fact Sheet

U.S. Food and Drug Administration (FDA)-approved prescription drug labeling is the most authoritative mechanism for communicating information about a medicine’s safety and effectiveness to health care providers. The approved labeling summarizes key scientific information about a medicine that hea...
https://www.phrma.org/fact-sheet/biosimilars-labeling

Fact Check Friday: The truth about Industry’s role in R&D

PhRMA  |  Blog Post

In fact, just 12 percent of drugs entering clinical trials ever make it to patients and thousands won’t even reach past the early discovery and pre-clinical testing stages.
http://catalyst.phrma.org/fact-check-friday-the-truth-about-industrys-role-in-r-and-d

RxE HCV in New Mexico

PhRMA  |  Fact Sheet

The past couple years have seen a transformation in treatment with the introduction of a new generation of HCV medicines which provide cure rates upwards of 90% with minimal side effects and in as little as 8 weeks.
https://www.phrma.org/fact-sheet/rxe-hcv-in-new-mexico

Medicare Monday: Fact Checking

PhRMA  |  Blog Post

  You can always check in with our Fact Check Friday posts here, or subscribe to updates .hubspot.com/ctas/v2/public/cs/c/?
http://catalyst.phrma.org/medicare-monday-fact-checking

Nebraska's 2016 Exchange Plans

PhRMA  |  Fact Sheet

Potential Size of Exchange Market: About 221,000 Nebraska residents State oversight can help ensure that health insurance exchange coverage offers the access to needed medicines the Affordable Care Act promised. States can continue to protect patients in their state thr...
https://www.phrma.org/fact-sheet/nebraska-s-2016-exchange-plans

Michigan's 2016 Exchange Plans

PhRMA  |  Fact Sheet

Potential Size of Exchange Market: About 733,000 Michigan residents State oversight can help ensure that health insurance exchange coverage offers the access to needed medicines the Affordable Care Act promised. States can continue to protect patients in their state thr...
https://www.phrma.org/fact-sheet/michigan-s-2016-exchange-plans

Missouri's 2016 Exchange Plans

PhRMA  |  Fact Sheet

Potential Size of Exchange Market: About 587,000 Missouri residents State oversight can help ensure that health insurance exchange coverage offers the access to needed medicines the Affordable Care Act promised. States can continue to protect patients in their state thr...
https://www.phrma.org/fact-sheet/missouri-s-2016-exchange-plans

You have reviewed the first 50 results out of 1200. Each page contains 25 results. You're on page 2.

prev 1 2 3 4 5 6 next